ENTRY       D11028                      Drug
NAME        Cenegermin (INN);
            Cenegermin-bkbj;
            Oxervate (TN)
PRODUCT     OXERVATE (Domp√© farmaceutici S.p.A.)
SEQUENCE    SSSHPIFHRG EFSVCDSVSV WVGDKTTATD IKGKEVMVLG EVNINNSVFK QYFFETKCRD
            PNPVDSGCRG IDSKHWNSYC TTTHTFVKAL TMDGKQAAWR FIRIDTACVC VLSRKAVR
            (Disulfide bridge: 15-80, 58-108, 68-110)
  TYPE      Peptide
REMARK      ATC code: S01XA24
            Product: D11028<US>
EFFICACY    Antiglaucoma, Neuroprotectant
COMMENT     recombinant human nerve growth factor [HSA:4803] [KO:K02582]
            Treatment of moderate to severe neurotrophic keratitis
TARGET      NGFR (TNFRSF16, CD271) [HSA:4804] [KO:K02583]
  PATHWAY   hsa04060(4804)  Cytokine-cytokine receptor interaction
            hsa04722(4804)  Neurotrophin signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01X OTHER OPHTHALMOLOGICALS
                S01XA Other ophthalmologicals
                 S01XA24 Cenegermin
                  D11028  Cenegermin (INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Ophthalmic Agents
              Ophthalmic Agents, Other
               Recombinant Human Nerve Growth Factor
                Cenegermin
                 D11028  Cenegermin (INN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                NGFR (TNFRSF16, CD271)
                 D11028  Cenegermin (INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11028
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11028
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11028
DBLINKS     CAS: 1772578-74-1
            PubChem: 350078347
///
